News

  The Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology, Prize for Science and Technology is presented to entities that have been particularly successful in areas such as conducting research and development into and promoting an understanding of science and technology. By celebrating successes like these, the award is intended to increase motivation among people involved in science and technology and contribute to improvements in the level of science and technology in Japan. 
  This is the second time Sysmex has received this award, the first being in fiscal 2007 for the Development of Reagent to Measure Immature Cells in the Blood.

  Classifying and counting white blood cells (including abnormal cells) is extremely important from the perspective of diagnosing disease. White blood cells are generally classified into five types: lymphocyte, monocyte, neutrophil, eosinophil and basophil. The ratio and number of these white blood cells may change as the result of disease. However, in testing with automated hematology analyzers, it was difficult to distinguish between normal and abnormal white blood cells, and the presence of abnormal cells makes accurate classification and counting difficult to achieve.
  The technology for which Sysmex was awarded the Commendation for Science and Technology by the Minister of Education, Culture, Sports, Science and Technology receives high marks for its ability to classify and count blood cells quickly and to a high degree of precision, even in samples that contain abnormal cells-a task that had proven difficult in the past. These results meet customers' needs for clinical testing that is performed with increasing speed and efficiency. 
  This technology is used on Sysmex's automated hematology analyzers, including the XE, XT and XS series, as well as the Company's latest model, the XN-Series. By providing healthcare professionals throughout the world with highly reliable blood test data, we support physicians' efforts to diagnose and treat illness and contribute to health maintenance.

 
 Going forward, Sysmex will continue promoting technological research with the aim of increasing the quality and efficiency of testing. At the same time, we will pursue research and development aimed at providing the high-quality data needed to provide healthcare that is optimized for individual patients.